Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Greater understanding of the risk factors and mechanisms of incident dementia in stroke survivors is needed for prevention and management. There is limited information on the long-term consequences and forms of incident dementia in older stroke survivors. We recruited 355 patients aged >75 years from hospital-based stroke registers into a longitudinal study 3 months after stroke. At baseline none of the patients had dementia. Patients were genotyped for apolipoprotein E and assessed annually for cognition and development of incident dementia over up to 8 years of follow-up. The effect of baseline vascular risk factors upon incidence of dementia and mortality were estimated by Cox proportional regression analyses adjusted for age and gender. Standard neuropathological examination was performed to diagnose the first 50 cases that came to autopsy. We found that the median survival from the date of the index stroke was 6.72 years (95% confidence intervals: 6.38-7.05). During the follow-up of a mean time of 3.79 years, 23.9% of subjects were known to have developed dementia and 76.1% remained alive without dementia or died without dementia. The incidence of delayed dementia was calculated to be 6.32 cases per 100 person years whereas that for death or dementia was 8.62. Univariate and multivariate regression analyses showed that the most robust predictors of dementia included low (1.5 standard deviations below age-matched control group) baseline Cambridge Cognitive Examination executive function and memory scores, Geriatric Depression Scale score and three or more cardiovascular risk factors. Autopsy findings suggested that remarkably ≥ 75% of the demented stroke survivors met the current criteria for vascular dementia. Demented subjects tended to exhibit marginally greater neurofibrillary pathology including tauopathy and Lewy bodies and microinfarcts than non-demented survivors. Despite initial improvements in cognition following stroke in older stroke survivors, risk of progression to delayed dementia after stroke is substantial, but is related to the presence of vascular risk factors. Careful monitoring and treatment of modifiable vascular risk factors may be of benefit in preventing post-stroke dementia in the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Risk factors for PSD include increasing age, female sex, prestroke cognitive decline, poststroke cognitive impairment, recurrent stroke, multiple vascular risk factors (in particular, atrial fibrillation, smoking, and diabetes mellitus), depression, early seizures, and low educational status. 103,185,189-191,197,198”
From Vascular Cognitive Impairment (2017) · cites this paper as [190]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of at least 4 vascular risk factors increases the risk of dementia or death by 4-fold in elderly stroke survivors, 190”
From Vascular Cognitive Impairment (2017) · cites this paper as [190]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We previously reported in the longitudinal Newcastle Cognitive Function After Stroke (CogFAST) study that ≈ 1 in 4 post‐ischemic stroke survivors developed clinical features of dementia and would survive for a median age of ≈ 6.72 years.”
From High vulnerability of medial prefrontal pyramidal neurons in post-stroke, vascular, Alzheimer's disease, and aging-related dementias (2026) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intriguingly, nearly 80% of PSD cases fulfil diagnostic criteria for vascular dementia (VaD), with features of cerebral small vessel disease and thus represent a subtype of VaD”
From High vulnerability of medial prefrontal pyramidal neurons in post-stroke, vascular, Alzheimer's disease, and aging-related dementias (2026) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“Stroke doubles the risk for dementia (post-stroke dementia), and approximately 30% of stroke patients go on to develop cognitive dysfunction within 3 years (Allan et al., 2011; Leys et al., 2005; Pendlebury and Rothwell, 2009).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Allan et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · cited 3×
“The lack of association of individual vascular risk factors does not take account of the potentially cumulative effect of multiple vascular risk factors in some patients, influencing the progression of both small vessel and large vessel disease.”
BackgroundResultPendlebury, S. T., & Rothwell, P. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70236-4 · Cited by 1,853 · cited 5×
“In the recent meta-analysis studies of post-stroke dementia in 22 separate cohorts (Pendlebury and Rothwell, 2009a), prevalence of post-stroke dementia up to 1 year was 20.3% in hospital-based Values are mean SD, unless noted otherwise.”
BackgroundInfluentialScheltens, P., Leys, D., Barkhof, F., Huglo, D., Weinstein, H. C., Vermersch, P., Kuiper, M., Steinling, M., Wolters, E. C., & Valk, J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.967 · Cited by 1,784
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722 · cited 1×
“They also suggest that the treatment or reduction of vascular risk factors in old age requires clinical trials with more than a single agent approach, especially if the burden of vascular dementia or vascular cognitive impairment is to be reduced (Hachinski et al., 2006).”
BackgroundSelf-citationChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201 · cited 1×
“…general absence of a high burden of neurofibrillary pathology i.e. Braak staging 5IV (Kalaria et al., 2004) or obvious other primary neurodegenerative disease, and consistent with the clinical diagnostic criteria proposed by others (Chui et al., 1992, 2000; Roman et al., 1993; Gold et al., 2002).”
ResultLeys, D., Hénon, H., Mackowiak-Cordoliani, M.-A., & Pasquier, F. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70221-0 · Cited by 609
Incidence and Prediction of Falls in Dementia: A Prospective Study in Older People
Allan, L. M., Ballard, C. G., Rowan, E. N., & Kenny, R. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005521 · Cited by 527 · cited 1×
“In addition to this full cohort, a subgroup of 35 of the stroke survivors who were already demented at baseline were recruited into a study of falls in dementia, ongoing within the same department (Allan et al., 2009).”
BackgroundSelf-citationDementia after ischemic stroke: A population-based study in Rochester, Minnesota (1960-1984)
Kokmen, E., Whisnant, J. P., O'Fallon, W. M., Chu, C.-P., & Beard, C. M. (1996) · Neurology · doi:10.1212/wnl.46.1.154 · Cited by 434
Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort
Tatemichi, T. K., Desmond, D. W., Mayeux, R., Paik, M., Stern, Y., Sano, M., Remien, R. H., Williams, J. B. W., Mohr, J. P., Hauser, W. A., et al. (1992) · Neurology · doi:10.1212/wnl.42.6.1185 · Cited by 420
Burton, E. J., Barber, R., Mukaetova-Ladinska, E. B., Robson, J., Perry, R. H., Jaros, E., Kalaria, R. N., & O’Brien, J. T. (2009) · Brain · doi:10.1093/brain/awn298 · Cited by 370 · cited 4×
“, 2011) consistent with the Alzheimer’s disease scenario (Burton et al., 2009), they exhibited medial temporal lobe atrophy as a prominent feature associated with cognitive decline after stroke (Bombois et al.”
BackgroundResultInfluentialSelf-citation
Research works printed but not linked: 6
- H non, 2003, Journal of neurology, 250, 10, 10.1007/s00415-003-0917-3 · DOI
- 2002, Journal of the neurological sciences, 203204, 29
- 2009, Journal of Neurology, Neurosurgery & Psychiatry, 80, 865, 10.1136/jnnp.2008.166603 · DOI
- 2009, Journal of Neurology, Neurosurgery & Psychiatry, 80, 1230, 10.1136/jnnp.2009.174573 · DOI · Paper page
- 2009, Cerebrovascular diseases (Basel, Switzerland), 27, 1
- 2002, Journal of the neurological sciences, 203204, 49
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“Stroke doubles the risk for dementia (poststroke dementia), and approximately 30% of stroke patients go on to develop cognitive dysfunction within 3 years (Allan et al., 2011; Leys et al., 2005; Pendlebury and Rothwell, 2009).”
O'Brien, J. T., & Thomas, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00463-8 · Cited by 1,136
Self-citationPost-Stroke Cognitive Impairment and Dementia
Rost, N. S., Brodtmann, A., Pase, M. P., van Veluw, S. J., Biffi, A., Duering, M., Hinman, J. D., & Dichgans, M. (2022) · Circulation Research · doi:10.1161/circresaha.122.319951 · Cited by 790
Stroke injury, cognitive impairment and vascular dementia
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.015 · Cited by 647
Self-citationPendlebury, S. T., & Rothwell, P. M. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30442-3 · Cited by 620
Dichgans, M., & Leys, D. (2017) · Circulation Research · doi:10.1161/circresaha.116.308426 · Cited by 581
“Because of the prominent appearance of WMH and lacunes on MRI, their anatomic location within white and deep gray matter, and a characteristic profile of associated clinical features, investigators have coined the terms subcortical ischemic vascular disease and subcortical ischemic VaD.20,21,74–76 However, the consequ…”
BackgroundInfluentialKalaria, R. N. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1571-z · Cited by 441
“1 3 within 3 months or after a stabilisation period of a year or longer after stroke injury [4, 16, 133].”
BackgroundSelf-citationPrevalence of Poststroke Cognitive Impairment: South London Stroke Register 1995–2010
Douiri, A., Rudd, A. G., & Wolfe, C. D. A. (2013) · Stroke · doi:10.1161/strokeaha.112.670844 · Cited by 377
“However, a stepwise progression of cognitive impairment frequencies was observed among stroke survivors with SVO and lacunar infarct stroke, which may represent progressive vascular dementia associated with stroke.(3) Other studies have shown that the progressive cognitive decline of these groups could be related to v…”
BackgroundResultInfluentialFu, C., Wu, Y., Liu, S., Luo, C., Lu, Y., Liu, M., Wang, L., Zhang, Y., & Liu, X. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115021 · Cited by 358
Pathology and pathogenesis of vascular cognitive impairment—a critical update
Jellinger, K. A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00017 · Cited by 353
“Cognitive impairment occurs after stroke in 6–41% of patients but can also arise from covert CVD (Ferrer, 2010; Pendlebury and Rothwell, 2009; Allan et al., 2011).”
BackgroundThe pathology and pathophysiology of vascular dementia
Kalaria, R. N. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.030 · Cited by 339
Self-citationThe role of the medial prefrontal cortex in cognition, ageing and dementia
Jobson, D. D., Hase, Y., Clarkson, A. N., & Kalaria, R. N. (2021) · Brain Communications · doi:10.1093/braincomms/fcab125 · Cited by 338
“220,221 Current studies suggest analogous trends to svMCI for this increasingly important PIS population in terms of variable mPFC associations.”
Self-citationPrevalence of dementia subtypes in United States Medicare fee‐for‐service beneficiaries, 2011–2013
Goodman, R. A., Lochner, K. A., Thambisetty, M., Wingo, T. S., Posner, S. F., & Ling, S. M. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.002 · Cited by 326
“However, estimates of the occurrence of this subtype likely will change as a function of an evolving understanding of the relation between vascular disease, the role of stroke, and neurodegenerative pathology [30-32].”
Stroke, Vascular Dementia, and Alzheimer’s Disease: Molecular Links
Vijayan, M., & Reddy, P. H. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160527 · Cited by 261
“Stroke doubles the risk for dementia (post-stroke dementia), and approximately 30% of stroke patients go on to develop cognitive dysfunction within 3 years [67, 68].”
BackgroundKalaria, R. N. (2012) · Stroke · doi:10.1161/strokeaha.112.655803 · Cited by 227
Self-citationThe impact of cerebrovascular aging on vascular cognitive impairment and dementia
Yang, T., Sun, Y., Lu, Z., Leak, R. K., & Zhang, F. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.007 · Cited by 205
“Recent clinical studies indicate that VCID occurs in about 25-30% of elderly stroke survivors (Allan et al., 2011; Savva et al., 2010).”
AIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice
Kim, H., Seo, J. S., Lee, S.-Y., Ha, K.-T., Choi, B. T., Shin, Y.-I., Ju Yun, Y., & Shin, H. K. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.011 · Cited by 187
Chen, A., Akinyemi, R. O., Hase, Y., Firbank, M. J., Ndung’u, M. N., Foster, V., Craggs, L. J. L., Washida, K., Okamoto, Y., Thomas, A. J., et al. (2016) · Brain · doi:10.1093/brain/awv328 · Cited by 172
Self-citationGemmell, E., Bosomworth, H., Allan, L., Hall, R., Khundakar, A., Oakley, A. E., Deramecourt, V., Polvikoski, T. M., O'Brien, J. T., & Kalaria, R. N. (2012) · Stroke · doi:10.1161/strokeaha.111.636498 · Cited by 166
Self-citationEarly-onset and delayed-onset poststroke dementia — revisiting the mechanisms
Mok, V. C. T., Lam, B. Y. K., Wong, A., Ko, H., Markus, H. S., & Wong, L. K. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.16 · Cited by 158
Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia
Wang, F., Cao, Y., Ma, L., Pei, H., Rausch, W. D., & Li, H. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00376 · Cited by 157
“Aging, obesity, hypertension, diabetes, hypercholesterolemia, hyperhomocysteinemia, atherosclerosis, and stroke are the risk factors for VaD (Roman, 2003; Lu F.P. et al., 2009; Maron and Loscalzo, 2009; Allan et al., 2011; Gottesman et al., 2014; Yang T. et al., 2017).”
BackgroundDing, R., Hase, Y., Ameen‐Ali, K. E., Ndung'u, M., Stevenson, W., Barsby, J., Gourlay, R., Akinyemi, T., Akinyemi, R., Uemura, M. T., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12888 · Cited by 145
“The VaD, PSD and PSND subjects were from the Newcastle Cognitive Function after Stroke study (2).”
MethodSelf-citationKhan, A., Kalaria, R. N., Corbett, A., & Ballard, C. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654987 · Cited by 125
“particularly in people carrying the APOE4 gene(14,15) although most PSD is pathologically confirmed as poststroke VaD.(11) Neuroimaging and neuropathological examination have enabled refinements of the clinical diagnostic criteria for cerebrovascular disorders that cause CI.”
BackgroundInfluentialSelf-citationWhite matter capillaries in vascular and neurodegenerative dementias
Hase, Y., Ding, R., Harrison, G., Hawthorne, E., King, A., Gettings, S., Platten, C., Stevenson, W., Craggs, L. J. L., & Kalaria, R. N. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0666-x · Cited by 101
Self-citationStroke, cerebrovascular diseases and vascular cognitive impairment in Africa
Akinyemi, R., Owolabi, M. O., Ihara, M., Damasceno, A. A. M., Ogunniyi, A. O., Dotchin, C. L., Paddick, S., Ogeng’o, J. A., Walker, R. W., & Kalaria, R. N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.018 · Cited by 111
“In rural Tanzania, both mild cognitive impairment (MCI) and dementia particularly vascular dementia (VaD) were associated with excess mortality relative to those without cognitive impairment [110].”
BackgroundInfluentialSelf-citationDementia in Patients Hospitalized with Stroke: Rates, Time Course, and Clinico-Pathologic Factors
Pendlebury, S. T. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00837.x · Cited by 97
“%) had VaD and 15 (37”
BackgroundInfluentialAkinyemi, R., Allan, L. M., Owolabi, M. O., Akinyemi, J. O., Ogbole, G. I., Ajani, A. A., Firbank, M., Ogunniyi, A. O., & Kalaria, R. N. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.08.042 · Cited by 104
Self-citationLong-Term Effects of Secondary Prevention on Cognitive Function in Stroke Patients
Douiri, A., McKevitt, C., Emmett, E. S., Rudd, A. G., & Wolfe, C. D. A. (2013) · Circulation · doi:10.1161/circulationaha.113.002236 · Cited by 92
Lana, D., Ugolini, F., & Giovannini, M. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.585833 · Cited by 100
Delayed‐onset dementia after stroke or transient ischemic attack
Mok, V., Lam, B. Y. K., Wang, Z., Liu, W., Au, L. W. C., Leung, E. Y. L., Chen, S., Yang, J., Chu, C. W., Lau, A. Y. L., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.05.007 · Cited by 90
Structural and Functional Remodeling of the Brain Vasculature Following Stroke
Andrade, M. F., Raman‐Nair, J., & Lacoste, B. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00948 · Cited by 88
“Stroke doubles the risk for dementia (post-stroke dementia), and approximately 30% of stroke survivors develop cognitive dysfunction within 3 years (Allan et al., 2011; Vijayan and Reddy, 2016).”
BackgroundBurden and Predictors of Poststroke Cognitive Impairment in a Sample of Ghanaian Stroke Survivors
Sarfo, F. S., Akassi, J., Adamu, S., Obese, V., & Ovbiagele, B. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.05.041 · Cited by 82
Portegies, M. L. P., Koudstaal, P. J., & Ikram, M. A. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00014-8 · Cited by 119
Yang, Z., Wang, H., Edwards, D., Ding, C., Yan, L., Brayne, C., & Mant, J. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100962 · Cited by 83
Wang, Z., van Veluw, S. J., Wong, A., Liu, W., Shi, L., Yang, J., Xiong, Y., Lau, A. Y. L., Biessels, G. J., & Mok, V. (2016) · Stroke · doi:10.1161/strokeaha.115.012278 · Cited by 91
“1,20,21 To date, CMIs have not been assessed in vivo in stroke populations, which are likely to have a higher vascular risk burden than in patients presenting to memory clinics.”
Verdelho, A., Wardlaw, J. M., Pavlovic, A. M., Pantoni, L., Godefroy, O., Duering, M., Charidimou, A., Chabriat, H., & Biessels, G. J. (2021) · European Stroke Journal · doi:10.1177/23969873211000258 · Cited by 79
Adav, S. S., & Sze, S. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0272-9 · Cited by 70
Post-Stroke Neuropsychiatric Complications: Types, Pathogenesis, and Therapeutic Intervention
Zhou, J., Fangma, Y., Chen, Z., & Zheng, Y. (2023) · Aging and Disease · doi:10.14336/ad.2023.0310-2 · Cited by 96
“It has been well documented that older age is the leading risk factor for PSCID, which is consistent with the high morbidity of stroke-related dementia in elderly [15].”
BackgroundThe Role of Processing Speed in Post-Stroke Cognitive Dysfunction
Su, C. Y., Wuang, Y.-P., Lin, Y.-H., & Su, J.-H. (2015) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acu057 · Cited by 79
“…Grand, Le Bas, & Hommel, 2010; Nys et al., 2007; Tatemichi et al., 1994), comorbid neurodegenerative disease (most commonly Alzheimer’s disease) (Allan et al., 2011), and structural abnormalities (presence of silent infarcts, white matter (WM) lesions, and cerebral atrophy) (Tatemichi et al.,…”
BackgroundCerebral Hypoxia: Its Role in Age-Related Chronic and Acute Cognitive Dysfunction
Snyder, B., Simone, S. M., Giovannetti, T., & Floyd, T. F. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005525 · Cited by 74
Kim, Y. J., Kim, S. M., Jeong, D. H., Lee, S.-K., Ahn, M.-E., & Ryu, O.-H. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00620-5 · Cited by 68
Sachdev, P. S., Lo, J., Crawford, J. D., Mellon, L., Hickey, A., Williams, D. J., Bordet, R., Mendyk, A., Gelé, P., Deplanque, D., et al. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.10.006 · Cited by 72
Self-citationIhle-Hansen, H., Thommessen, B., Fagerland, M. W., Øksengård, A. R., Wyller, T. B., Engedal, K., & Fure, B. (2014) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00928.x · Cited by 64
Morphometry of the hippocampal microvasculature in post‐stroke and age‐related dementias
Burke, M. J. C., Nelson, L., Slade, J. Y., Oakley, A. E., Khundakar, A. A., & Kalaria, R. N. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12085 · Cited by 63
Self-citationCerebral small vessel disease and post-stroke cognitive impairment
Teng, Z., Dong, Y., Zhang, D., An, J., & Lv, P. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1261291 · Cited by 69
Biological and imaging predictors of cognitive impairment after stroke: a systematic review
Casolla, B., Caparros, F., Cordonnier, C., Bombois, S., Hénon, H., Bordet, R., Orzi, F., & Leys, D. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9089-z · Cited by 72
Foster, V., Oakley, A. E., Slade, J. Y., Hall, R., Polvikoski, T. M., Burke, M., Thomas, A. J., Khundakar, A., Allan, L. M., & Kalaria, R. N. (2014) · Brain · doi:10.1093/brain/awu172 · Cited by 62
“In general, nNeuropathological assessment was carried out as described previously (Allan et al., 2011; Gemmell et al., 2012).”
BackgroundMethodInfluentialSelf-citationAssociation of diabetes with stroke and post‐stroke dementia: A population‐based cohort study
Shang, Y., Fratiglioni, L., Marseglia, A., Plym, A., Welmer, A., Wang, H., Wang, R., & Xu, W. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12101 · Cited by 68
Schaapsmeerders, P., van Uden, I. W. M., Tuladhar, A. M., Maaijwee, N. A. M., van Dijk, E. J., Rutten‐Jacobs, L. C. A., Arntz, R. M., Schoonderwaldt, H. C., Dorresteijn, L. D. A., de Leeuw, F., et al. (2015) · Human Brain Mapping · doi:10.1002/hbm.22782 · Cited by 76
Identification of novel circulatory microRNA signatures linked to patients with ischemic stroke
Vijayan, M., Kumar, S., Yin, X., Zafer, D., Chanana, V., Cengiz, P., & Reddy, P. H. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy136 · Cited by 60
Xiong, L., Boulouis, G., Charidimou, A., Roongpiboonsopit, D., Jessel, M. J., Pasi, M., Reijmer, Y. D., Fotiadis, P., Ayres, A. M., Merrill, E., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17700435 · Cited by 65
Chaudhari, T. S., Verma, R. K., Garg, R. K., Singh, M. K., Malhotra, H. S., & Sharma, P. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.03.018 · Cited by 62
ROCK as a therapeutic target for ischemic stroke
Sladojević, N., Yu, B., & Liao, J. K. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1395700 · Cited by 58
“Stroke survivors have more than twice the risk of developing dementia compared with people who never had stroke [66].”
BackgroundSevere white matter astrocytopathy in CADASIL
Hase, Y., Chen, A., Bates, L. L., Craggs, L. J. L., Yamamoto, Y., Gemmell, E., Oakley, A. E., Korolchuk, V. I., & Kalaria, R. N. (2018) · Brain Pathology · doi:10.1111/bpa.12621 · Cited by 56
Self-citationNeuropathologic Correlates of Cognition in a Population-Based Sample
Cholerton, B., Larson, E. B., Baker, L. D., Craft, S., Crane, P. K., Millard, S. P., Sonnen, J. A., & Montine, T. J. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130281 · Cited by 54
“disease (AD), vascular brain injury (VBI), and/or Lewy body disease (LBD) are the major predictors of clinical dementia diagnosis in older individuals [1–3].”
Chen, A., Oakley, A. E., Monteiro, M., Tuomela, K., Allan, L. M., Mukaetova-Ladinska, E. B., O'Brien, J. T., & Kalaria, R. N. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.021 · Cited by 52
“Neuropathological assessment was carried out as described previously, using standardized protocols (Allan et al., 2011; Ihara et al., 2010; Kalaria et al., 2004).”
MethodInfluentialSelf-citationAssociation between Risk Factors for Vascular Dementia and Adiponectin
Song, J., Lee, W. T., Park, K. A., & Lee, J. E. (2014) · BioMed Research International · doi:10.1155/2014/261672 · Cited by 67
Long-term incidence of depression and predictors of depressive symptoms in older stroke survivors
Allan, L. M., Rowan, E. N., Thomas, A. J., Polvikoski, T. M., O'Brien, J. T., & Kalaria, R. N. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.128355 · Cited by 51
Self-citationLewandowski, S. A., Fredriksson, L., Lawrence, D. A., & Eriksson, U. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.016 · Cited by 58
Neurovascular Ageing and Age-Related Diseases
Kalaria, R. N., & Hase, Y. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_17 · Cited by 58
Self-citationHase, Y., Polvikoski, T. M., Firbank, M., Craggs, L., Hawthorne, E., Platten, C., Stevenson, W., Deramecourt, V., Ballard, C. G., Kenny, R. A., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12769 · Cited by 56
Self-citationCraggs, L. J. L., Fenwick, R., Oakley, A. E., Ihara, M., & Kalaria, R. N. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12188 · Cited by 48
Self-citationCraggs, L. J. L., Yamamoto, Y., Ihara, M., Fenwick, R., Burke, M., Oakley, A. E., Roeber, S., Duering, M., Kretzschmar, H., & Kalaria, R. N. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12073 · Cited by 47
Self-citationWeaver, N. A., Zhao, L., Biesbroek, J. M., Kuijf, H. J., Aben, H. P., Bae, H., Caballero, M. Á. A., Chappell, F. M., Chen, C., Dichgans, M., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.02.007 · Cited by 48
Self-citationGut dysbiosis in stroke and its implications on Alzheimer’s disease‐like cognitive dysfunction
Cho, J., Park, Y. J., Gonzales‐Portillo, B., Saft, M., Cozene, B., Sadanandan, N., & Borlongan, C. V. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13613 · Cited by 46
Akinyemi, R., Allan, L. M., Oakley, A. E., & Kalaria, R. N. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00717 · Cited by 48
“They were classified as post-stroke non-demented (PSND) if CAMCOG score was >80 and Clinical Dementia Rating (CDR) was less than 1, but as post-stroke demented (PSD) if CAMCOG score was<80 and CDR score was>1 (Allan et al., 2011).”
MethodSelf-citationDepression, Vascular Factors, and Risk of Dementia in Primary Care: A Retrospective Cohort Study
Köhler, S., Buntinx, F., Palmer, K., & van den Akker, M. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13357 · Cited by 88
Mixed dementia: Neglected clinical entity or nosographic artifice?
Fierini, F. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116662 · Cited by 51
Gaps in care for patients with memory deficits after stroke: views of healthcare providers
Tang, E. Y. H., Price, C., Stephan, B. C. M., Robinson, L. A., & Exley, C. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2569-5 · Cited by 46
“They found that although 41% were stable and 50% improved in cognition after 15 months, a significant proportion of post-stroke survivors succumbed to delayed post-stroke dementia [29, 30].”
BackgroundVascular Dementia: From Pathophysiology to Therapeutic Frontiers
Yang, H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186611 · Cited by 52
“SIVD typically presents with a “subcortical syndrome” characterized by prominent executive dysfunction, slowed processing speed, and gait disturbances, with memory being relatively preserved in the early stages [29].”
Ding, R., Hase, Y., Burke, M., Foster, V., Stevenson, W., Polvikoski, T. M., & Kalaria, R. N. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01230-6 · Cited by 43
Self-citationPeng, D., Wang, Y.-X., Huang, T., Luo, D., Qiao, L., Wang, Q., Guan, L., Cai, Y., & Zhang, S. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6664990 · Cited by 41
Neuron Volumes in Hippocampal Subfields in Delayed Poststroke and Aging-Related Dementias
Gemmell, E., Tam, E., Allan, L. M., Hall, R., Khundakar, A. A., Oakley, A. E., Thomas, A. J., Deramecourt, V., & Kalaria, R. N. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000054 · Cited by 40
Self-citationMolecular Links and Biomarkers of Stroke, Vascular Dementia, and Alzheimer's Disease
Vijayan, M., Kumar, S., Bhatti, J. S., & Reddy, P. H. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.014 · Cited by 41
“Stroke doubles the risk for dementia (poststroke dementia), and approximately 30% of stroke patients go on to develop cognitive dysfunction within 3 years.(53,54) The association between”
BackgroundSasaki, Y., Aida, J., Tsuji, T., Miyaguni, Y., Tani, Y., Koyama, S., Matsuyama, Y., Sato, Y., Tsuboya, T., Nagamine, Y., et al. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx274 · Cited by 43
“It has also been found to be a good predictor of health status, including cognitive function and dementia (26, 27).”
BackgroundAdav, S. S., Qian, J., Ang, Y. L., Kalaria, R. N., Lai, M. K. P., Chen, C., & Sze, S. K. (2014) · Journal of Proteome Research · doi:10.1021/pr500754j · Cited by 36
Self-citationRohde, D., Merriman, N. A., Doyle, F., Bennett, K., Williams, D. J., & Hickey, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189339 · Cited by 38
Effects of the FNDC5/Irisin on Elderly Dementia and Cognitive Impairment
Peng, J., & Wu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.863901 · Cited by 49
Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors
Meng, X., & D'Arcy, C. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3918 · Cited by 34
“Previous findings of associations between earlier health histories of depression, diabetes, stroke, and others, and late onset of dementia have generally found significant results (Ownby et al., 2006; Andersen et al., 2005; Cheng et al., 2011; Allan et al., 2011).”
BackgroundNeuroimaging predictors of death and dementia in a cohort of older stroke survivors
Firbank, M., Allan, L. M., Burton, E. J., Barber, R., O'Brien, J. T., & Kalaria, R. N. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300873 · Cited by 37
Self-citationGaynor, E., Rohde, D., Large, M., Mellon, L., Hall, P., Brewer, L., Conway, O., Hickey, A., Bennett, K., Dolan, E., et al. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.05.002 · Cited by 34
Mikkola, T. S., Savolainen-Peltonen, H. M., Tuomikoski, P., Hoti, F. J., Vattulainen, P., Gissler, M., & Ylikorkala, O. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3590 · Cited by 38
Hase, Y., Jobson, D., Cheong, J., Gotama, K. T., Maffei, L., Hase, M., Hamdan, A., Ding, R., Polivkoski, T., Horsburgh, K. J., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01737-8 · Cited by 35
“The PSND, PSD and VaD groups were derived from the New-castle Cognitive Function After Stroke (CogFAST) study [1].”
MethodSelf-citationHase, Y., Polvikoski, T. M., Ihara, M., Hase, M., Zafar, R., Stevenson, W., Allan, L. M., Ennaceur, A., Horsburgh, K. J., Gallart‐Palau, X., et al. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12550 · Cited by 35
Self-citationCognitive Impairment in Patients with Stroke
D’Souza, C. E., Greenway, M. R. F., Graff‐Radford, J., & Meschia, J. F. (2021) · Seminars in Neurology · doi:10.1055/s-0040-1722217 · Cited by 38
Pathogenesis and Treatment of Vascular Cognitive Impairment
Jellinger, K. A. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.37 · Cited by 34
Kim, Y., Lim, J.-S., Oh, M. S., Yu, K., Lee, J. S., Park, J.-H., Kim, Y., Rha, J., Hwang, Y., Heo, S. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83945-z · Cited by 31
Understanding and preventing the development of post-stroke dementia
Ihara, M., & Kalaria, R. N. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.947276 · Cited by 34
“Consistent with this, a prospective longitudinal study [8] revealed that presence of three or more cardiovascular risk factors increased risk of dementia or death by fourfold in Table 1.”
BackgroundInfluentialSelf-citationThe link between Alzheimer’s disease and stroke: A detrimental synergism
Behl, T., Kaur, I., Sehgal, A., Khandige, P. S., Imran, M., Gulati, M., Anwer, M. K., Elossaily, G. M., Ali, N., Wal, P., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102388 · Cited by 38
Zhang, Y., Xu, H., Zhao, Y., Zhang, L., & Zhang, Y. (2021) · Neurological Research · doi:10.1080/01616412.2020.1866245 · Cited by 30
“The simple mental state scale (MMSE) and Montreal cognitive assessment scale (MoCA) are commonly used in clinical practice to evaluate CI, but the sensitivity and objectivity of the scales to evaluate vascular CI in early stages are poor, thus delaying diagnosis [8].”
MethodLigustilide ameliorates cognitive impairment via AMPK/SIRT1 pathway in vascular dementia rat
Peng, D., Qiao, H., Tan, H.-Y., Wang, Y.-X., Luo, D., Qiao, L., Cai, Y., Zhang, S., Wang, Q., & Guan, L. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00947-0 · Cited by 31
“…cells of neurovascular unit have specialized receptors that will release potent signaling molecules (nitric oxide, endothelin) to adapt the cerebral blood supply with its energetic The most common causes of VaD are chronic cerebral hypoperfusion and stroke (Iadecola 2013; Allan et al. 2011).”
BackgroundGait Measures as Predictors of Poststroke Cognitive Function: Evidence From the TABASCO Study
Assayag, E. B., Shenhar‐Tsarfaty, S., Korczyn, A. D., Kliper, E., Hallevi, H., Shopin, L., Auriel, E., Giladi, N., Mike, A., Halevy, A., et al. (2015) · Stroke · doi:10.1161/strokeaha.114.007346 · Cited by 38
“In most cases, however, the cerebrovascular changes in the brain appeared to explain poststroke CD better than only the presence of primary neurodegenerative disease pathology.(14) We, therefore, suggest that in most of the decliners, the stroke may have triggered or hastened cognitive deterioration in a cause and eff…”
BackgroundAkinyemi, R., Firbank, M., Ogbole, G. I., Allan, L. M., Owolabi, M. O., Akinyemi, J. O., Yusuf, B. P., Ogunseyinde, O. A., Ogunniyi, A. O., & Kalaria, R. N. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1552-7 · Cited by 31
“reduced hippocampal volume in a cohort of men, while hippocampal neuronal atrophy was found to correlate with PSD in another cohort with insignificant degenerative pathology [33, 34].”
BackgroundSelf-citationAtrial Fibrillation is Independently Associated with Cognitive Impairment after Ischemic Stroke
Chander, R. J., Lim, L., Handa, S., Hiu, S. K. W., Choong, A., Lin, X., Singh, R., Oh, D. C. T., & Kandiah, N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170313 · Cited by 31
“They include age [3], education [3, 8], acute infarcts [2, 3], silent infarcts [9], cardiovascular risk factors [10], and small vessel disease [11].”
Trajectories of cognitive change following stroke: stepwise decline towards dementia in the elderly
Delgado, J., Masoli, J., Hase, Y., Akinyemi, R., Ballard, C., Kalaria, R. N., & Allan, L. M. (2022) · Brain Communications · doi:10.1093/braincomms/fcac129 · Cited by 28
“Stroke remains a leading cause of death, long-term disability and cognitive impairment.(2,3) There is an established link between incident stroke and cognitive de-”
BackgroundMethodResultSelf-citationThe Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study
Aam, S., Gynnild, M. N., Munthe‐Kaas, R., Saltvedt, I. T., Lydersen, S., Knapskog, A., Ihle‐Hansen, H., Ellekjær, H., Eldholm, R. S., & Fure, B. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.678794 · Cited by 28
The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment
Sforza, M., Bianchini, E., Alivernini, D., Salvetti, M., Pontieri, F. E., & Sette, G. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02546-w · Cited by 34
The Association Between Stroke, Depression, and 5-Year Mortality Among Very Old People
Hörnsten, C., Lövheim, H., & Gustafson, Y. (2013) · Stroke · doi:10.1161/strokeaha.113.002202 · Cited by 26
Hase, Y., Ameen‐Ali, K. E., Waller, R., Simpson, J. E., Stafford, C., Mahesh, A., Ryan, L., Pickering, L., Bodman, C., Hase, M., et al. (2022) · Brain Pathology · doi:10.1111/bpa.13101 · Cited by 27
“The types of strokes and follow-up period, which could potentially have effects on brain inflammatory changes, were not different between PSND and PSD groups in this cohort [1].”
BackgroundMethodInfluentialSelf-citationKalaria, R. N., Akinyemi, R., Paddick, S., & Ihara, M. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2273393 · Cited by 30
“Current evidence also shows cumulative vascular disease risk factors worsen neurocognitive deficits [68] and promote depression [32] as well as severe frailty [69,70].”
BackgroundSelf-citation
Metadata
- Authors
- Allan, L. M., Rowan, E. N., Firbank, M. J., Thomas, A. J., Parry, S. W., Polvikoski, T. M., O'Brien, J. T., & Kalaria, R. N.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Allan, L. M.
- Kalaria, R. N.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-12-01
- Volume
- 134
- Issue
- 12
- Pages
- 3716-3727
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3235558
- OpenAlex
- W2138876608
- Cited by
- 225
- References
- 56
- Citations by year
- 2026: 3 · 2025: 16 · 2024: 26 · 2023: 10 · 2022: 21 · 2021: 21 · 2020: 12 · 2019: 16 · 2018: 11 · 2017: 18 · 2016: 20 · 2015: 13 · 2014: 19 · 2013: 10 · 2012: 7
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Funders
- Medical Research Council (G0400074, G0500247)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- post-stroke dementia, stroke survivors, older adults, dementia incidence, mortality, vascular risk factors, apolipoprotein E, executive function, memory, Geriatric Depression Scale, vascular dementia, neuropathology, tauopathy, Lewy bodies, microinfarcts, neurofibrillary pathology
- MeSH terms
- Aged, Aged, 80 and over, Apolipoproteins E, Dementia, Female, Follow-Up Studies, Genotype, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Risk Factors, Incidence, Survivors, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.